U.S. Markets closed

Stryker downgraded to Reduce from Neutral at SunTrust

SunTrust downgraded Stryker to Reduce due to reform initiatives and near-term product headwinds. The firm's survey indicates ACO's, CMS bundling, and readmission will negatively impact hips and knees pricing. Price target raised to $56 from $53.